Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxRevenueShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Metlife (MET-PF) EBT (2016 - 2025)

Metlife has reported EBT over the past 17 years, most recently at $1.1 billion for Q4 2025.

  • Quarterly results put EBT at $1.1 billion for Q4 2025, down 19.12% from a year ago — trailing twelve months through Dec 2025 was $4.7 billion (down 17.09% YoY), and the annual figure for FY2025 was $4.7 billion, down 17.09%.
  • EBT for Q4 2025 was $1.1 billion at Metlife, down from $1.2 billion in the prior quarter.
  • Over the last five years, EBT for MET-PF hit a ceiling of $4.5 billion in Q2 2021 and a floor of $257.0 million in Q1 2023.
  • Median EBT over the past 5 years was $1.2 billion (2024), compared with a mean of $1.4 billion.
  • Peak annual rise in EBT hit 2177.66% in 2021, while the deepest fall reached 94.84% in 2021.
  • Metlife's EBT stood at $1.7 billion in 2021, then grew by 19.32% to $2.0 billion in 2022, then plummeted by 53.55% to $941.0 million in 2023, then soared by 46.76% to $1.4 billion in 2024, then decreased by 19.12% to $1.1 billion in 2025.
  • The last three reported values for EBT were $1.1 billion (Q4 2025), $1.2 billion (Q3 2025), and $980.0 million (Q2 2025) per Business Quant data.